Long-Term Follow-Up of Bridging Therapies Prior to CAR T-Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma

SIMPLE SUMMARY: Bridging therapy (BT) in the form of systemic therapy (ST), radiation therapy (RT), or combined-modality therapy (CMT) is increasingly being utilized prior to chimeric antigen receptor (CAR) T-cell therapy for large B-cell lymphoma (LBCL). Prior institutional experiences with BT, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ladbury, Colton, Dandapani, Savita, Hao, Claire, Fabros, Mildred, Amini, Arya, Sampath, Sagus, Glaser, Scott, Sokolov, Karen, Yeh, Jekwon, Baird, John H., Kambhampati, Swetha, Herrera, Alex, Mei, Matthew, Nikolaenko, Liana, Shouse, Geoffrey, Budde, Lihua E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046245/
https://www.ncbi.nlm.nih.gov/pubmed/36980632
http://dx.doi.org/10.3390/cancers15061747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046245/
https://www.ncbi.nlm.nih.gov/pubmed/36980632
http://dx.doi.org/10.3390/cancers15061747

Ejemplares similares